Indoco Remedies gets boost from USFDA

Shares of Indoco Remedies will remain in focus, as the company, in a post-market hours disclosure on Monday, said it has received a nod from the US Food and Drug Administration for its Goa unit. It has a manufacturing capacity of 2.2 billion tablets, 32 million bottles of liquid orals, 16 million tubes of creams and ointments and 60 million capsules of hard gelatin. This brings to a close the USFDA inspection of October 2015.